Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
Marta Velia Antonini, Hematologist, Perfusionist ECMO and NRP Specialist and Chair of the Normothermic Regional Perfusion EuroELSO Working Group, shared on X:
“sNO in anticoagulation-contraindicated adult ECMO to provide localized antiplatelet activity at blood-circuit interface without intentionally inducing systemic anticoagulation??
10 patients with clinically significant bleeding risk 3 VV, 6 VA, 1 VP; 90% survived to decannulation
NO delivered at 20 ppm via a system connected to ML sweep-gas pathway for 2–72 days; systemic anticoagulation and antiplatelets withheld
no ML replacement for thrombosis, gas-exchange failure, pressure drop elevation, hemolysis
ML ΔP remained below 50 mm Hg in all patients
MAX MetHb 1-3.4%
no patient required sNO discontinuation
sNO was feasible in this series, and not associated with NO-attributable safety events/complications”

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 16:54James P. Crowley: DOAC Testing Under 50 ng/mL Safely Expedites Urgent Hip Fracture Surgery
-
Nov 8, 2026, 16:21Alessandra Bosch: Women and Girls With Bleeding Disorders and the DACH Registries at HHS 2026
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026